Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegileridine vs sufentanil with paravertebral block for postoperative pain after gastric cancer surgery
ChiCTR2500112238Phase 4Not yet recruiting
- Sponsor
- Fujian Medical University Union Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (2 arms), sponsored by Fujian Medical University Union Hospital. Primary endpoints: SPID24 at rest and SPID48 at rest. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500112238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500112238.